Cat. No. Name Size Price Add Cart
KI3420BMS-554417QuoteQuote

Chemical Characteristic

Product NameBMS-554417
CAS No.468741-42-6
Molecular Weight 532
FormulaC28H30ClN7O2
Chemical Name4-[2-[4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-1,2-dihydro-2-oxo-3-pyridinyl]-7-methyl-1H-benzimidazol-5-yl]-1-piperazinepropanenitrile
SmilesC(#N)CCN1CCN(CC1)c1cc2c([nH]c(n2)c2c(=O)[nH]ccc2NC[C@@H](O)c2cc(ccc2)Cl)c(c1)C
Chemical Structure

Biological activities

BMS-554417 is a inhibitor of IGF1R/IR and inhibits focal adhesion kinase (FAK) activity.[1] The IC50s of BMS-554417 are 68, 51, and 90 nM against IGF-IR, IR, and FAK, respectively.[2] BMS-554417 has antiproliferative and proapoptotic activity in vitro and in vivo.[3] In Jurkat T-cell leukemia cells, BMS-554417 triggers apoptotic cell death via the mitochondrial pathway, and induce apoptotic cell morphologic changes at 2.5 µM.[1][3] In breast and ovarian cancer cell lines, the IC50s of BMS-554417 for proliferation ranged from 0.218 to 8.5 µM. In vitro, BMS-554417 inhibits ERK phosphorylation and causes a G0/G1 arrest and prevents nuclear accumulation of cyclin D1 in response to LR3 IGF-I. Meanwhile, BMS-554417 decreases Akt phosphorylation at Ser473 and inhibits the PI3k/Akt pathway.[3] In vivo, BMS-554417 blocks both IGF-I??ediated and insulin-mediated signaling events and reduces salivary gland tumor xenografts growth.[4] In a mouse allograft model, oral administration of BMS-554417??00 mg/kg once daily??hows significant antitumor efficacy in mice.[2]

Protocols

In vitro, BMS-554417 is dissolved in DMSO.[2]

References

[1]Haluska P, et al. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417. Cancer Res. 2006, 66(1):362-371.
[2]Wang Y, et al. Inhibition of the IGF-I receptor for treatment of cancer. Kinase inhibitors and monoclonal antibodies as alternative approaches. Recent Results Cancer Res. 2007, 172:59-76.
[3]Haluska, Paul, et al. "BMS-554417, an inhibitor of the insulin-like growth factor I receptor and insulin receptor, inhibits proliferation and induces mitochondrial pathway-mediated apoptosis in cancer cell lines." Proceedings of the American Association for Cancer Research 2005.1 (2005): 1191.
[4]Zhang H, et al. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin. Cancer Res. 2007, 67(1):391-397.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.